Clinical trial
Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults
NCT00327678 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00327678 |
|---|---|
| Title | Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults |
| Official title | Young Adult With Acute Lymphoblastic Leukemia (ALL) : a Multicentric Protocol. GRAALL 2005 : T ALL or B ALL Non Ph GRAALL 2005 R : B ALL Non Ph CD20+ GRAAPH 2005 : ALL Ph |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Collaborators | Group for Research in Adult Acute Lymphoblastic Leukemia |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphocytic |
| Intervention type | Drug |
| Interventions | Rituximab, Imatinib Mesylate |
| Enrollment | 1,080 |
| Start date | May 1, 2006 |
| Primary completion | Apr 1, 2014 |
| Completion | Apr 1, 2014 |
| First posted | May 18, 2006 |
| Last update posted | Jun 27, 2016 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: